Pfizer's Kristofco comments on outcomes-oriented CME

Share this article:

During an MM&M webcast, Pfizer's Bob Kristofco, MSW, said pharma “continues to have an expectation for more outcomes-oriented CME,” and that he expects grants from public and private sources will “begin to assess the current climate for [CPD].”

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions